NEU 3.76% $14.35 neuren pharmaceuticals limited

Phelan-McDermid Syndrome, page-84

  1. 1,225 Posts.
    lightbulb Created with Sketch. 313
    can’t agree more. We are about to have over $200m in the bank and predictable quarterly royalties. The management gotta be thinking how to best manage the capital to get the best returns for the shareholders. I can’t see why the company needs to hold onto the $200m right now given the future cash inflows
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.35
Change
0.520(3.76%)
Mkt cap ! $1.834B
Open High Low Value Volume
$13.96 $14.35 $13.66 $6.469M 457.9K

Buyers (Bids)

No. Vol. Price($)
3 2023 $14.27
 

Sellers (Offers)

Price($) Vol. No.
$14.38 1777 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.